Saleh A. Naser - Publications

Affiliations: 
University of Central Florida, Orlando, FL, United States 
Area:
Immunology, Cell Biology, Molecular Biology

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Kuenstner JT, Xu Q, Bull TJ, Foddai ACG, Grant IR, Naser SA, Potula R, Zhang P, Shafran I, Akhanli SE, Khaiboullina S, Kruzelock R. Cytokine expression in subjects with ssp. positive blood cultures and a meta-analysis of cytokine expression in Crohn's disease. Frontiers in Cellular and Infection Microbiology. 14: 1327969. PMID 38415011 DOI: 10.3389/fcimb.2024.1327969  0.369
2022 Louis TJ, Qasem A, Naser SA. Attenuation of Excess TNF-α Release in Crohn's Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking. Frontiers in Immunology. 13: 887830. PMID 35585977 DOI: 10.3389/fimmu.2022.887830  0.349
2022 Vaccaro JA, Qasem A, Naser SA. Cathelicidin Mediates an Anti-Inflammatory Role of Active Vitamin D (Calcitriol) During Infection. Frontiers in Cellular and Infection Microbiology. 12: 875772. PMID 35444957 DOI: 10.3389/fcimb.2022.875772  0.31
2020 Kuenstner JT, Potula R, Bull TJ, Grant IR, Foddai A, Naser SA, Bach H, Zhang P, Yu D, Lu X, Shafran I. Presence of Infection by subsp. in the Blood of Patients with Crohn's Disease and Control Subjects Shown by Multiple Laboratory Culture and Antibody Methods. Microorganisms. 8. PMID 33371478 DOI: 10.3390/microorganisms8122054  0.409
2020 Qasem A, Elkamel E, Naser SA. Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn's Disease through Downregulation of NF-κB Activation in the Absence of MAP Detection. Biomedicines. 8. PMID 33217961 DOI: 10.3390/biomedicines8110513  0.346
2020 AlQasrawi D, Qasem A, Naser SA. Divergent Effect of Cigarette Smoke on Innate Immunity in Inflammatory Bowel Disease: A Nicotine-Infection Interaction. International Journal of Molecular Sciences. 21. PMID 32823518 DOI: 10.3390/Ijms21165801  0.378
2019 Qasem A, Ramesh S, Naser SA. Genetic polymorphisms in tumour necrosis factor receptors () illustrate differential treatment response to TNFα inhibitors in patients with Crohn's disease. Bmj Open Gastroenterology. 6: e000246. PMID 30815272 DOI: 10.1136/Bmjgast-2018-000246  0.398
2019 Graham DY, Naser SA, Offman E, Kassir N, Hardi R, Welton T, Rydzewska G, Stepien B, Arlukowicz T, Wos A, Fehrmann C, Anderson P, Bibliowicz A, McLean P, Fathi R, et al. 643 RHB-104, a Fixed-Dose, Oral Antibiotic Combination Against Mycobacterium Avium Paratuberculosis (MAP) Infection, Is Effective in Moderately to Severely Active Crohn's Disease The American Journal of Gastroenterology. 114. DOI: 10.14309/01.Ajg.0000592108.53051.68  0.395
2018 Sharp RC, Naser ES, Alcedo KP, Qasem A, Abdelli LS, Naser SA. Development of multiplex PCR and multi-color fluorescent in situ hybridization (-FISH) coupled protocol for detection and imaging of multi-pathogens involved in inflammatory bowel disease. Gut Pathogens. 10: 51. PMID 30534203 DOI: 10.1186/S13099-018-0278-1  0.451
2018 Qasem A, Naser SA. TNFα inhibitors exacerbate infection in tissue culture: a rationale for poor response of patients with Crohn's disease to current approved therapy. Bmj Open Gastroenterology. 5: e000216. PMID 30073091 DOI: 10.1136/Bmjgast-2018-000216  0.502
2018 Cao BL, Qasem A, Sharp RC, Abdelli LS, Naser SA. Systematic review and meta-analysis on the association of tuberculosis in Crohn's disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα). World Journal of Gastroenterology. 24: 2764-2775. PMID 29991880 DOI: 10.3748/Wjg.V24.I25.2764  0.392
2018 Naser A, Qasem A, Naser SA. Mycobacterial infection influences bone biomarker levels in Crohn's disease. Canadian Journal of Physiology and Pharmacology. PMID 29638140 DOI: 10.1139/Cjpp-2017-0700  0.429
2018 Sharp RC, Beg SA, Naser SA. Role ofpolymorphisms in pathophysiology of Crohn's disease. World Journal of Gastroenterology. 24: 657-670. PMID 29456405 DOI: 10.3748/Wjg.V24.I6.657  0.454
2018 Sharp RC, Beg SA, Naser SA. Polymorphisms inAre Linked to Hyper-Proliferative T-Cells and Susceptibility toin Rheumatoid Arthritis. Frontiers in Cellular and Infection Microbiology. 8: 11. PMID 29423382 DOI: 10.3389/Fcimb.2018.00011  0.338
2018 Rohr M, Narasimhulu CA, Sharma D, Doomra M, Riad A, Naser S, Parthasarathy S. Inflammatory Diseases of the Gut. Journal of Medicinal Food. PMID 29389238 DOI: 10.1089/Jmf.2017.0138  0.35
2017 Kuenstner JT, Naser S, Chamberlin W, Borody T, Graham DY, McNees A, Hermon-Taylor J, Hermon-Taylor A, Dow CT, Thayer W, Biesecker J, Collins MT, Sechi LA, Singh SV, Zhang P, et al. The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017. Frontiers in Public Health. 5: 208. PMID 29021977 DOI: 10.3389/Fpubh.2017.00208  0.371
2017 Qasem A, Naser AE, Naser SA. The alternate effects of anti-TNFa therapeutics and their role in mycobacterial granulomatous infection in Crohn's disease. Expert Review of Anti-Infective Therapy. PMID 28481651 DOI: 10.1080/14787210.2017.1328276  0.49
2016 Qasem A, Safavikhasraghi M, Naser SA. A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn's disease associated with Mycobacterium avium subspecies paratuberculosis. Gut Pathogens. 8: 45. PMID 27708718 DOI: 10.1186/S13099-016-0127-Z  0.398
2016 Alcedo KP, Thanigachalam S, Naser SA. RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis. Gut Pathogens. 8: 32. PMID 27307791 DOI: 10.1186/S13099-016-0115-3  0.52
2016 Qasem A, Abdel-Aty A, Abu-Suwa H, Naser SA. Oxidative stress due to Mycobacterium avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx activity. Gut Pathogens. 8: 12. PMID 26997979 DOI: 10.1186/S13099-016-0090-8  0.347
2015 Sharp RC, Abdulrahim M, Naser ES, Naser SA. Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease. Frontiers in Cellular and Infection Microbiology. 5: 95. PMID 26734582 DOI: 10.3389/Fcimb.2015.00095  0.369
2015 Kuenstner JT, Chamberlin W, Naser SA, Collins MT, Dow CT, Aitken JM, Weg S, Telega G, John K, Haas D, Eckstein TM, Kali M, Welch C, Petrie T. Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis. World Journal of Gastroenterology. 21: 4048-62. PMID 25852293 DOI: 10.3748/Wjg.V21.I13.4048  0.45
2014 Naser SA, Abdelsalam A, Thanigachalam S, Naser AS, Alcedo K. Domino effect of hypomagnesemia on the innate immunity of Crohn's disease patients. World Journal of Diabetes. 5: 527-35. PMID 25126398 DOI: 10.4239/Wjd.V5.I4.527  0.424
2014 Naser SA, Sagramsingh SR, Naser AS, Thanigachalam S. Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients. World Journal of Gastroenterology. 20: 7403-15. PMID 24966610 DOI: 10.3748/Wjg.V20.I23.7403  0.552
2013 Naser SA, Thanigachalam S, Dow CT, Collins MT. Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study. Gut Pathogens. 5: 14. PMID 23759115 DOI: 10.1186/1757-4749-5-14  0.32
2013 Naser SA, Thanigachalam S, Spinelli N, Safavi MM, Naser N, Khan O. The 19 kDa Protein from Mycobacterium avium subspecies paratuberculosis Is a Glycolipoprotein Ai Magazine. 3: 520-528. DOI: 10.4236/Aim.2013.37070  0.339
2012 Kaittanis C, Boukhriss H, Santra S, Naser SA, Perez JM. Rapid and sensitive detection of an intracellular pathogen in human peripheral leukocytes with hybridizing magnetic relaxation nanosensors. Plos One. 7: e35326. PMID 22496916 DOI: 10.1371/Journal.Pone.0035326  0.381
2012 Naser SA, Arce M, Khaja A, Fernandez M, Naser N, Elwasila S, Thanigachalam S. Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis. World Journal of Gastroenterology. 18: 412-24. PMID 22346247 DOI: 10.3748/Wjg.V18.I5.412  0.467
2011 Pierce ES, Borowitz SM, Naser SA. The Broad Street pump revisited: dairy farms and an ongoing outbreak of inflammatory bowel disease in Forest, Virginia. Gut Pathogens. 3: 20. PMID 22196128 DOI: 10.1186/1757-4749-3-20  0.355
2011 Naser SA, Romero C, Urbina P, Naser N, Valentine J. Cellular infiltration and cytokine expression correlate with fistulizing state in Crohn's disease. Clinical and Vaccine Immunology : Cvi. 18: 1416-9. PMID 21752952 DOI: 10.1128/Cvi.05095-11  0.693
2010 Shin AR, Kim HJ, Cho SN, Collins MT, Manning EJ, Naser SA, Shin SJ. Identification of seroreactive proteins in the culture filtrate antigen of Mycobacterium avium ssp. paratuberculosis human isolates to sera from Crohn's disease patients. Fems Immunology and Medical Microbiology. 58: 128-37. PMID 19878316 DOI: 10.1111/J.1574-695X.2009.00617.X  0.496
2009 Naser SA, Romero C, Elwasila S, Ghonaim M, Naser N, Valentine JF. Functional Dysregulation of PBMC and PMN in Crohn's Disease The Open Inflammation Journal. 2: 24-33. DOI: 10.2174/1875041900902010024  0.723
2009 Naser SA, Collins MT, Crawford JT, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis (MAP) from the Blood of Patients with Crohn`s disease: A Follow-Up Blind Multi Center Investigation The Open Inflammation Journal. 2: 22-23. DOI: 10.2174/1875041900902010022  0.488
2008 Zhu X, Tu ZJ, Coussens PM, Kapur V, Janagama H, Naser S, Sreevatsan S. Transcriptional analysis of diverse strains Mycobacterium avium subspecies paratuberculosis in primary bovine monocyte derived macrophages. Microbes and Infection / Institut Pasteur. 10: 1274-82. PMID 18692151 DOI: 10.1016/J.Micinf.2008.07.025  0.316
2008 Beckler DR, Elwasila S, Ghobrial G, Valentine JF, Naser SA. Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease. World Journal of Gastroenterology. 14: 2723-30. PMID 18461657 DOI: 10.3748/Wjg.14.2723  0.329
2008 Chamberlin W, Naser SA. Blood cultures of 19 Crohn's disease patients. The American Journal of Gastroenterology. 103: 802-3. PMID 18341502 DOI: 10.1111/J.1572-0241.2007.01612_6.X  0.388
2008 Valentine JF, Elam J, Naser SA. M2062 ATG16L1 (Autophagy-Related 16-Like 1) Crohn's Disease (CD) Associated SNP Is Not Associated with Viable Mycobacterium avium Subspecies Paratuberculosis (MAP) in the Blood of CD Patients Gastroenterology. 134: A-461. DOI: 10.1016/S0016-5085(08)62155-1  0.489
2007 Chamberlin W, Borody T, Naser S. MAP-associated Crohn's disease MAP, Koch's postulates, causality and Crohn's disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 39: 792-4. PMID 17611175 DOI: 10.1016/J.Dld.2007.05.012  0.44
2007 Chamberlin W, Ghobrial G, Chehtane M, Naser SA. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis. The American Journal of Gastroenterology. 102: 689-91. PMID 17335456 DOI: 10.1111/J.1572-0241.2007.01040_7.X  0.382
2007 Kaittanis C, Naser SA, Perez JM. One-step, nanoparticle-mediated bacterial detection with magnetic relaxation. Nano Letters. 7: 380-3. PMID 17298004 DOI: 10.1021/Nl062553Z  0.313
2006 Rumsey J, Valentine JF, Naser SA. Inhibition of phagosome maturation and survival of Mycobacterium avium subspecies paratuberculosis in polymorphonuclear leukocytes from Crohn's disease patients. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 12: BR130-9. PMID 16572045  0.36
2006 Wu CW, Glasner J, Collins M, Naser S, Talaat AM. Whole-genome plasticity among Mycobacterium avium subspecies: insights from comparative genomic hybridizations. Journal of Bacteriology. 188: 711-23. PMID 16385061 DOI: 10.1128/Jb.188.2.711-723.2006  0.33
2005 Naser SA, Collins MT. Debate on the lack of evidence of Mycobacterium avium subsp. paratuberculosis in Crohn's disease. Inflammatory Bowel Diseases. 11: 1123. PMID 16306778 DOI: 10.1097/01.Mib.0000191609.20713.Ea  0.436
2005 Naser SA, Cohen RD. Mycobacterium in Crohn's disease is hard to digest [3] (multiple letters) Gastroenterology. 129: 1359-1361. PMID 16230095 DOI: 10.1053/J.Gastro.2005.08.042  0.392
2005 Romero C, Hamdi A, Valentine JF, Naser SA. Evaluation of surgical tissue from patients with Crohn's disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflammatory Bowel Diseases. 11: 116-25. PMID 15677904 DOI: 10.1097/00054725-200502000-00004  0.731
2004 Huggett J, Dheda K, Zumla A, Rook G, Naser SA, Valentine JF, Gaya DR, Black RA, MacKenzie JF. Crohn's disease and MAP [4] (multiple letters) Lancet. 364: 2178-2179. PMID 15610800 DOI: 10.1016/S0140-6736(04)17585-5  0.447
2004 Ghadiali AH, Strother M, Naser SA, Manning EJ, Sreevatsan S. Mycobacterium avium subsp. paratuberculosis strains isolated from Crohn's disease patients and animal species exhibit similar polymorphic locus patterns. Journal of Clinical Microbiology. 42: 5345-8. PMID 15528739 DOI: 10.1128/Jcm.42.11.5345-5348.2004  0.357
2004 Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet (London, England). 364: 1039-44. PMID 15380962 DOI: 10.1016/S0140-6736(04)17058-X  0.707
2004 Naser SA, Valentine JF. Crohn's disease and MAP The Lancet. 364: 2178-2179. DOI: 10.1016/S0140-6736(04)17586-7  0.348
2003 Motiwala AS, Strother M, Amonsin A, Byrum B, Naser SA, Stabel JR, Shulaw WP, Bannantine JP, Kapur V, Sreevatsan S. Molecular epidemiology of Mycobacterium avium subsp. paratuberculosis: evidence for limited strain diversity, strain sharing, and identification of unique targets for diagnosis. Journal of Clinical Microbiology. 41: 2015-26. PMID 12734243 DOI: 10.1128/Jcm.41.5.2015-2026.2003  0.325
2002 Shafran I, Piromalli C, Decker JW, Sandoval J, Naser SA, El-Zaatari FA. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients. Digestive Diseases and Sciences. 47: 2079-81. PMID 12353858 DOI: 10.1023/A:1019685131692  0.445
2002 Naser SA, Shafran I, Schwartz D, El-Zaatari F, Biggerstaff J. In situ identification of mycobacteria in Crohn's disease patient tissue using confocal scanning laser microscopy Molecular and Cellular Probes. 16: 41-48. PMID 12005446 DOI: 10.1006/Mcpr.2001.0395  0.538
2002 Shafran I, Kugler L, El-Zaatari FA, Naser SA, Sandoval J. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 34: 22-8. PMID 11930899 DOI: 10.1016/S1590-8658(02)80055-X  0.393
2001 Chamberlin W, Graham DY, Hulten K, El-Zimaity HMT, Schwartz MR, Naser S, Shafran I, El-Zaatari FAK. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease Alimentary Pharmacology and Therapeutics. 15: 337-346. PMID 11207508 DOI: 10.1046/J.1365-2036.2001.00933.X  0.407
2001 Naser SA, Ghobrial G, Miles H. Effect of nicotine on inflammatory bowel disease The American Journal of Gastroenterology. 96: 3455-3457. DOI: 10.1016/S0002-9270(01)03915-6  0.304
2000 Schwartz D, Shafran I, Romero C, Piromalli C, Biggerstaff J, Naser N, Chamberlin W, Naser SA. Use of short-term culture for identication of Mycobacterium avium subsp. paratuberculosis in tissue from Cronhs's disease patients Clinical Microbiology and Infection. 6: 303-307. PMID 11168138 DOI: 10.1046/J.1469-0691.2000.00093.X  0.731
2000 Hulten K, Karttunen TJ, El-Zimaity HM, Naser SA, Almashhrawi A, Graham DY, El-Zaatari FA. In situ hybridization method for studies of cell wall deficient M. paratuberculosis in tissue samples. Veterinary Microbiology. 77: 513-8. PMID 11118736 DOI: 10.1016/S0378-1135(00)00336-9  0.355
2000 Naser SA, Hulten K, Shafran I, Graham DY, El-Zaatari FAK. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis Veterinary Microbiology. 77: 497-504. PMID 11118734 DOI: 10.1016/S0378-1135(00)00334-5  0.444
2000 Hulten K, Karttunen TJ, El-Zimaity HM, Naser SA, Collins MT, Graham DY, El-Zaatari FA. Identification of cell wall deficient forms of M. avium subsp. paratuberculosis in paraffin embedded tissues from animals with Johne's disease by in situ hybridization. Journal of Microbiological Methods. 42: 185-95. PMID 11018275 DOI: 10.1016/S0167-7012(00)00185-8  0.404
2000 Naser SA, Schwartz D, Shafran I. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients [6] American Journal of Gastroenterology. 95: 1094-1095. PMID 10763975 DOI: 10.1111/J.1572-0241.2000.01954.X  0.346
2000 Shafran I, Piromalli CS, Naser S. Rifabutin and macrolide antibiotic treatment in Crohn's patients identified serologically positive for mycobacterium avium SS. paratuberculosis Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)85270-1  0.339
2000 Ira S, Piromalli C, Schwartz D, Romero C, Naser S. Identification of Mycobacterium avium ss. paratuberculosis in Crohn's tissue Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)83387-9  0.722
2000 Shafran I, Piromalli CS, Naser S. A comparitive analysis of anti-saccharomyces antibodies (ASCA) and p35 and p36 recombinant clones for the diagnosis of Crohn's disease (CD) Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)82502-0  0.405
1999 Naser SA, Felix J, Liping H, Romero C, Naser N, Walsh A, Safranek W. Occurrence of the IS900 gene in Mycobacterium avium complex derived from HIV patients. Molecular and Cellular Probes. 13: 367-72. PMID 10508558 DOI: 10.1006/Mcpr.1999.0261  0.637
1999 El-Zaatari FA, Naser SA, Hulten K, Burch P, Graham DY. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Current Microbiology. 39: 115-9. PMID 10398839 DOI: 10.1007/S002849900430  0.404
1999 Naser S, Shafran I. Mycobacterium avium subsp. paratuberculosis in Crohn's disease is serologically positive. Clinical and Vaccine Immunology. 6: 282-282. DOI: 10.1128/Cdli.6.2.282-282.1999  0.405
1997 El-Zaatari FA, Naser SA, Graham DY. Characterization of a specific Mycobacterium paratuberculosis recombinant clone expressing 35,000-molecular-weight antigen and reactivity with sera from animals with clinical and subclinical Johne's disease. Journal of Clinical Microbiology. 35: 1794-9. PMID 9196196 DOI: 10.1128/Jcm.35.7.1794-1799.1997  0.372
1996 el-Zaatari FA, Naser SA, Markesich DC, Kalter DC, Engstand L, Graham DY. Identification of Mycobacterium avium complex in sarcoidosis. Journal of Clinical Microbiology. 34: 2240-5. PMID 8862592 DOI: 10.1128/Jcm.34.9.2240-2245.1996  0.36
1995 el-Zaatari FA, Naser SA, Engstrand L, Burch PE, Hachem CY, Whipple DL, Graham DY. Nucleotide sequence analysis and seroreactivities of the 65K heat shock protein from Mycobacterium paratuberculosis. Clinical and Vaccine Immunology. 2: 657-664. DOI: 10.1128/Cdli.2.6.657-664.1995  0.383
1994 el-Zaatari FA, Naser SA, Engstrand L, Hachem CY, Graham DY. Identification and characterization of Mycobacterium paratuberculosis recombinant proteins expressed in E. coli. Current Microbiology. 29: 177-84. PMID 7765093 DOI: 10.1007/Bf01570760  0.38
Show low-probability matches.